bekbossynova-m 1
1. Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants
2. Genetic variants of ABCB1 and CES1 genes on dabigatran metabolism in the Kazakh population
3. The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC
4. Improvements in Cardiopulmonary Exercise Test Results in Atrial Fibrillation Patients After Radiofrequency Ablation in Kazakhstan
5. Anxiety and Depression Among Astana Reinfected Patients at 1-, 3-, and 6-Month Follow-Up in the Post-COVID Center
6. Apolipoprotein B and Glycemic Dysregulation: New Predictors of Type 2 Diabetes in High-Cardiovascular-Risk Populations
7. Beyond Cholesterol: Emerging Risk Factors in Atherosclerosis
8. Biochemical markers of myocardial contusion after blunt chest trauma
9. Central and effector memory T cells in peripheral blood of patients with interstitial pneumonia: preliminary clues from a COVID-19 study
10. Establishment of an Atherosclerosis and Dyslipidemia Program in Kazakhstan
11. Ethnic Variation in Lipoprotein(a) Levels in the Kazakhstan Population
12. Genetic variants and carotid atherosclerosis progression in familial hypercholesterolemia: a comprehensive review
13. Hypertension as a manifestation of COVID-19 pneumonia
14. Indirect Myocardial Injury in Polytrauma: Mechanistic Pathways and the Clinical Utility of Immunological Markers
15. Longitudinal Myocardial Deformation as an Emerging Biomarker for Post-Traumatic Cardiac Dysfunction
16. Proposing new lipoprotein (a) cut off value for Kazakhstan: pilot study
17. Prospective and Longitudinal Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Positive and Negative Pneumonia: Potential Role of Decreased Naïve CD8+ in COVID-19 Patients
18. Small dense LDL: An underestimated driver of atherosclerosis (Review)
19. The Kazakhstan Model for Heart Failure Care: A Nationally Integrated Approach to Advanced Cardiac Therapy
20. Unraveling Acute and Post-COVID Cytokine Patterns to Anticipate Future Challenges
21. Genetic Variants in Potassium Channel Genes and Their Clinical Implications in Kazakhstani Patients with Cardiac Arrhythmias
22. Short-Chain Fatty Acids and Their Metabolic Interactions in Heart Failure
23. Patients with coronary heart disease, dilated cardiomyopathy and idiopathic ventricular tachycardia share overlapping patterns of pathogenic variation in cardiac risk genes
24. Metagenomic Characterization of Gut Microbiota in Individuals with Low Cardiovascular Risk
25. The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure
26. Differences in cardiac mechanics assessed by left ventricular hemodynamic forces in athletes and patients with hypertension
27. Successful Heart Transplantation After 7 h of Cold Storage and Paracorporeal Donor Heart Resuscitation
28. A second update on mapping the human genetic architecture of COVID-19
29. Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases
30. Diagnostic and prognostic value of circulating biomarkers in heart failure
31. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
32. Gut Microbiome and Cytokine Profiles in Post-COVID Syndrome
33. First Clinical Experience With the Pressure Sensor-Based Autoregulation of Blood Flow in an Artificial Heart
34. Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand Factor
35. Case report: A novel surgical technique for rapid valve-in-ring implantation into the native aortic annulus during left ventricular assist device implantation
36. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan
37. Precise monitoring of transpulmonic resistance in bridge-to-transplant patients supported by the Aeson total artificial heart
38. Effects of Intense Physical Training on Left Ventricular Hemodynamic Forces in Endurance Athletes: A Feature-Tracking Cardiac Magnetic Resonance Study
39. Intradialytic Changes and Prognostic Value of Ventriculo-Arterial Coupling in Patients With End-Stage Renal Disease: Protocol for an Observational Prospective Trial
40. The impact of exercise on cardiovascular system: Molecular signaling pathway and cardiac adaptations
41. Enterococcus dysbiosis as a mediator of vitamin D deficiency-associated memory impairments
42. Impact of urbanization on gut microbiome mosaics across geographic and dietary contexts
43. Imaging Hope The Essential Role of Echocardiography in Heart Transplantation
44. Epidemiology of Arterial Hypertension in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014–2019
45. Incidence, mortality and disability-adjusted life years of acute myocardial infarction in Kazakhstan: data from unified national electronic healthcare system 2014–2019
46. Comparison of left ventricular hemodynamic forces measured by transthoracic echocardiography and cardiac magnetic resonance imaging in healthy adults
47. Cardiac imaging in athlete’s heart: current status and future prospects
1